{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics, numeric values, and units as required."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In one embodiment, isolated human antibodies of the invention bind to PSMA antigen with an affinity constant of at least about 10? M\"<sup>1</sup>, preferably about 10^ M\"<sup>1</sup>, more preferably, about l\u03b8\" M\"<sup>1</sup>, and more preferably about 10^0 to 1011 M\"l or stronger, and are capable of inhibiting growth and/or mediating phagocytosis and killing of cells expressing PSMA by human effector cells, e.g., polymorphonuclear cells (PMNs), monocytes and macrophages, with an IC50 of about 1 x 10\" M or less, or at a concentration of about 10 \u03bcg/ml or less in vitro.\n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: a) specificity for the PSMA; b) a binding affinity to PSMA with an affinity constant of at least about 10<sup>7</sup> M\" <sup>l</sup> , preferably about 10<sup>9</sup> M\" <sup>l</sup> , and more preferably, about 101 \u00b0 M\" 1 to 10<sup>1 1</sup> M\" <sup>l</sup> or higher; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... c) an association constant (K<sub>assoc</sub>) with PSMA of at least about 10<sup>3</sup>, more preferably about 10<sup>4</sup> and most preferably about 10<sup>5</sup> M^S<sup>\"1</sup>; \n* In another embodiment, human anti-PSMA antibodies of the present invention can be characterized by one or more of the following properties: ... d) a dissociation constant (K<sub>d</sub>i<sub>S</sub>) from PSMA of about 10\"3 s\"<sup>1</sup>, preferably about 10\"4 s\" 1 , more preferably, 10<sup>~</sup>5 s\" 1 , and most preferably, 10\"6 s\" 1 ;"}
{"final_json": [{"molecule_name": "human antibodies", "protein_target_name": "PSMA antigen", "binding_metric": "IC50", "value": "1 x 10\" M", "unit": "M", "is_logarithmic": false}, {"molecule_name": "human anti-PSMA antibodies", "protein_target_name": "PSMA", "binding_metric": "affinity constant", "value": "10^7 M\"1", "unit": "M\"1", "is_logarithmic": false}, {"molecule_name": "human anti-PSMA antibodies", "protein_target_name": "PSMA", "binding_metric": "affinity constant", "value": "10^9 M\"1", "unit": "M\"1", "is_logarithmic": false}, {"molecule_name": "human anti-PSMA antibodies", "protein_target_name": "PSMA", "binding_metric": "affinity constant", "value": "10^11 M\"1", "unit": "M\"1", "is_logarithmic": false}, {"molecule_name": "human anti-PSMA antibodies", "protein_target_name": "PSMA", "binding_metric": "K_assoc", "value": "10^3", "unit": "M^S\"1", "is_logarithmic": false}, {"molecule_name": "human anti-PSMA antibodies", "protein_target_name": "PSMA", "binding_metric": "K_assoc", "value": "10^4", "unit": "M^S\"1", "is_logarithmic": false}, {"molecule_name": "human anti-PSMA antibodies", "protein_target_name": "PSMA", "binding_metric": "K_assoc", "value": "10^5", "unit": "M^S\"1", "is_logarithmic": false}, {"molecule_name": "human anti-PSMA antibodies", "protein_target_name": "PSMA", "binding_metric": "K_d", "value": "10\"3 s\"1", "unit": "s\"1", "is_logarithmic": false}, {"molecule_name": "human anti-PSMA antibodies", "protein_target_name": "PSMA", "binding_metric": "K_d", "value": "10\"4 s\"1", "unit": "s\"1", "is_logarithmic": false}, {"molecule_name": "human anti-PSMA antibodies", "protein_target_name": "PSMA", "binding_metric": "K_d", "value": "10\"5 s\"1", "unit": "s\"1", "is_logarithmic": false}, {"molecule_name": "human anti-PSMA antibodies", "protein_target_name": "PSMA", "binding_metric": "K_d", "value": "10\"6 s\"1", "unit": "s\"1", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nTypically, the antibody binds with an affinity of at least about 1 x 10<sup>7</sup> M<sup>\"1</sup>, and binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\nAs used herein, the term \"high affinity\" for an IgG antibody refers to a binding affinity of at least about 10<sup>7</sup>M<sup>_1</sup>, preferably at least about \nHowever, \"high affinity\" binding can vary for other antibody isotypes. For example, \"high affinity\" binding for an IgM isotype refers to a binding affinity of at least about 1 x 10<sup>7</sup>M<sup>~</sup>\\"}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "affinity", "value": "1 x 10^7", "unit": "M^-1", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "affinity", "value": "10^7", "unit": "M^-1", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "affinity", "value": "1 x 10^7", "unit": "M~", "is_logarithmic": false}]}
